{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:55:45Z","timestamp":1782741345507,"version":"3.54.5"},"reference-count":287,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s12035-023-03328-5","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T03:14:54Z","timestamp":1681355694000},"page":"4206-4231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["RETRACTED ARTICLE: Exploring the Therapeutic Effect of Neurotrophins and Neuropeptides in Neurodegenerative Diseases: at a Glance"],"prefix":"10.1007","volume":"60","author":[{"given":"Md. Mominur","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Rezaul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatema Akter","family":"Supti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puja Sutro","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheikh","family":"Shohag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannatul","family":"Ferdous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakil khan","family":"shuvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aklima","family":"Akter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Sarowar","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3682-3573","authenticated-orcid":false,"given":"Rohit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,13]]},"reference":[{"key":"3328_CR1","doi-asserted-by":"publisher","first-page":"104795","DOI":"10.1016\/j.neubiorev.2022.104795","volume":"140","author":"R Sharma","year":"2022","unstructured":"Sharma R, Singla RK, Banerjee S, Sinha B, Shen B, Sharma R (2022) Role of Shankhpushpi (Convolvulus pluricaulis) in neurological disorders: an umbrella review covering evidence from ethnopharmacology to clinical studies. Neurosci Biobehav Rev 140:104795. https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104795. (Epub 2022 Jul 22. PMID: 35878793.)","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"3328_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000481812","volume":"25","author":"MS Uddin","year":"2018","unstructured":"Uddin MS, al Mamun A, Asaduzzaman M et al (2018) Spectrum of disease and prescription pattern for outpatients with neurological disorders: an empirical pilot study in Bangladesh. Ann Neurosci Karger Publishers 25(1):25\u201337","journal-title":"Ann Neurosci Karger Publishers"},{"issue":"22","key":"3328_CR3","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.2174\/1381612824666180821165741","volume":"24","author":"R Sharma","year":"2018","unstructured":"Sharma R, Kabra A, Rao MM, Prajapati PK (2018) Herbal and holistic solutions for neurodegenerative and depressive disorders: leads from Ayurveda. Curr Pharm Des 24(22):2597\u20132608. https:\/\/doi.org\/10.2174\/1381612824666180821165741. (PMID: 30147009)","journal-title":"Curr Pharm Des"},{"key":"3328_CR4","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","volume":"24","author":"EJ Huang","year":"2001","unstructured":"Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci Annu Rev Neurosci 24:677\u2013736","journal-title":"Annu Rev Neurosci Annu Rev Neurosci"},{"issue":"3","key":"3328_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0301-0082(02)00016-3","volume":"67","author":"PP Roux","year":"2002","unstructured":"Roux PP, Barker PA (2002) Neurotrophin signaling through the p75 neurotrophin receptor. Prog Neurobiol Prog Neurobiol 67(3):203\u2013233","journal-title":"Prog Neurobiol Prog Neurobiol"},{"issue":"3","key":"3328_CR6","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/0896-6273(92)90183-E","volume":"9","author":"LC Schecterson","year":"1992","unstructured":"Schecterson LC, Bothwell M (1992) Novel roles for neurotrophins are suggested by BDNF and NT-3 mRNA expression in developing neurons. Neuron Neuron 9(3):449\u2013463","journal-title":"Neuron Neuron"},{"key":"3328_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1146\/annurev.ne.19.030196.002335","volume":"19","author":"RA Segal","year":"1996","unstructured":"Segal RA, Greenberg ME (1996) Intracellular signaling pathways activated by neurotrophic factors. Annu Rev Neurosci Annu Rev Neurosci 19:463\u2013489","journal-title":"Annu Rev Neurosci Annu Rev Neurosci"},{"issue":"4","key":"3328_CR8","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/jnen\/62.4.340","volume":"62","author":"A Kruttgen","year":"2003","unstructured":"Kruttgen A, Saxena S, Evangelopoulos ME et al (2003) Neurotrophins and neurodegenerative diseases: receptors stuck in traffic? J Neuropathol Exp Neurol J Neuropathol Exp Neurol 62(4):340\u2013350","journal-title":"J Neuropathol Exp Neurol J Neuropathol Exp Neurol"},{"key":"3328_CR9","doi-asserted-by":"crossref","unstructured":"Numakawa T, Matsumoto T, Numakawa Y, et al (2011) Protective action of neurotrophic factors and estrogen against oxidative stress-mediated neurodegeneration. J Toxicol\u00a0","DOI":"10.1155\/2011\/405194"},{"key":"3328_CR10","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.freeradbiomed.2012.09.016","volume":"62","author":"K Dasuri","year":"2013","unstructured":"Dasuri K, Zhang L, Keller JN (2013) Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis. Free Radic Biol Med Free Radic Biol Med 62:170\u2013185","journal-title":"Free Radic Biol Med Free Radic Biol Med"},{"issue":"5","key":"3328_CR11","doi-asserted-by":"publisher","first-page":"698","DOI":"10.2174\/1871527311312050015","volume":"12","author":"R Rodrigo","year":"2013","unstructured":"Rodrigo R, Fernandz-Gajardo R, Gutierrez R et al (2013) Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities. CNS Neurol Disord Drug Targets CNS Neurol Disord Drug Targets 12(5):698\u2013714","journal-title":"CNS Neurol Disord Drug Targets CNS Neurol Disord Drug Targets"},{"key":"3328_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1196\/annals.1418.005","volume":"1144","author":"MP Mattson","year":"2008","unstructured":"Mattson MP (2008) Glutamate and neurotrophic factors in neuronal plasticity and disease. Ann N Y Acad Sci Ann N Y Acad Sci 1144:97\u2013112","journal-title":"Ann N Y Acad Sci Ann N Y Acad Sci"},{"key":"3328_CR13","doi-asserted-by":"crossref","unstructured":"Lakhan SE, Kirchgessner A, Hofer M (2009) Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med\u00a0 7","DOI":"10.1186\/1479-5876-7-97"},{"issue":"1473","key":"3328_CR14","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1098\/rstb.2006.1894","volume":"361","author":"LF Reichardt","year":"2006","unstructured":"Reichardt LF (2006) Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci Philos Trans R Soc Lond B Biol Sci 361(1473):1545\u20131564","journal-title":"Philos Trans R Soc Lond B Biol Sci Philos Trans R Soc Lond B Biol Sci"},{"issue":"3","key":"3328_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nrd3366","volume":"10","author":"AH Nagahara","year":"2011","unstructured":"Nagahara AH, Tuszynski MH (2011) Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat Rev Drug Discov Nat Rev Drug Discov 10(3):209\u2013219","journal-title":"Nat Rev Drug Discov Nat Rev Drug Discov"},{"key":"3328_CR16","doi-asserted-by":"crossref","unstructured":"Cai J, Hua F, Yuan L, et al (2014) Potential therapeutic effects of neurotrophins for acute and chronic neurological diseases. Biomed Res Int","DOI":"10.1155\/2014\/601084"},{"issue":"1","key":"3328_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000486225","volume":"45","author":"M Yi","year":"2018","unstructured":"Yi M, Li H, Wu Z et al (2018) A promising therapeutic target for metabolic diseases: neuropeptide Y receptors in humans. Cell Physiol Biochem 45(1):88\u2013107","journal-title":"Cell Physiol Biochem"},{"key":"3328_CR18","doi-asserted-by":"crossref","unstructured":"Thorsell A, Math\u00e9 AA (2017) Neuropeptide Y in alcohol addiction and affective disorders. Front Endocrinol (Lausanne)\u00a08(JUL)","DOI":"10.3389\/fendo.2017.00178"},{"issue":"53","key":"3328_CR19","doi-asserted-by":"publisher","first-page":"41921","DOI":"10.1074\/jbc.M110.164020","volume":"285","author":"R Ferreira","year":"2010","unstructured":"Ferreira R, Xapelli S, Santos T et al (2010) Neuropeptide Y modulation of interleukin-1{beta} (IL-1{beta})-induced nitric oxide production in microglia. J Biol Chem J Biol Chem 285(53):41921\u201341934","journal-title":"J Biol Chem J Biol Chem"},{"key":"3328_CR20","doi-asserted-by":"crossref","unstructured":"Li C, Wu X, Liu S, et al (2019) Roles of neuropeptide Y in neurodegenerative and neuroimmune diseases. Front Neurosci 13","DOI":"10.3389\/fnins.2019.00869"},{"key":"3328_CR21","first-page":"1703","volume":"15","author":"SN Rai","year":"2021","unstructured":"Rai SN, Tiwari N, Singh P et al (2021) Therapeutic potential of vital transcription factors in Alzheimer\u2019s and Parkinson\u2019s disease with particular emphasis on transcription factor EB mediated autophagy. Front Neurosci Frontiers Media SA 15:1703","journal-title":"Front Neurosci Frontiers Media SA"},{"issue":"8","key":"3328_CR22","first-page":"1","volume":"10","author":"D Chen","year":"2020","unstructured":"Chen D, Zhang T, Lee TH (2020) Cellular mechanisms of melatonin: insight from neurodegenerative diseases. Biomolecules MDPI AG 10(8):1\u201326","journal-title":"Biomolecules MDPI AG"},{"key":"3328_CR23","doi-asserted-by":"crossref","unstructured":"Lekoubou A, Echouffo-Tcheugui JB, Kengne AP (2014) Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review. BMC Public Health BioMed Central Ltd\u00a014(1)","DOI":"10.1186\/1471-2458-14-653"},{"issue":"7","key":"3328_CR24","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1089\/hum.2018.157","volume":"30","author":"C N\u00f3brega","year":"2019","unstructured":"N\u00f3brega C, Cod\u00easso JM, Mendon\u00e7a L et al (2019) RNA interference therapy for Machado-Joseph disease: long-term safety profile of lentiviral vectors encoding short hairpin RNAs targeting mutant ataxin-3. Hum Gene Ther 30(7):841\u2013854","journal-title":"Hum Gene Ther"},{"issue":"1","key":"3328_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.13439","volume":"25","author":"CA Lane","year":"2018","unstructured":"Lane CA, Hardy J, Schott JM (2018) Alzheimer\u2019s disease. Eur J Neurol 25(1):59\u201370","journal-title":"Eur J Neurol"},{"issue":"11","key":"3328_CR26","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.15252\/embj.201695810","volume":"36","author":"S Camandola","year":"2017","unstructured":"Camandola S, Mattson MP (2017) Brain metabolism in health, aging, and neurodegeneration. EMBO J 36(11):1474\u20131492","journal-title":"EMBO J"},{"issue":"13","key":"3328_CR27","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.2174\/1567205016666190903102822","volume":"16","author":"AK Singh","year":"2019","unstructured":"Singh AK, Mishra G, Maurya A et al (2019) Role of TREM2 in Alzheimer\u2019s disease and its consequences on \u03b2-amyloid, tau and neurofibrillary tangles. Curr Alzheimer Res Bentham Science Publishers Ltd 16(13):1216\u20131229","journal-title":"Curr Alzheimer Res Bentham Science Publishers Ltd"},{"issue":"3","key":"3328_CR28","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/ana.410200303","volume":"20","author":"MF Beal","year":"1986","unstructured":"Beal MF, Mazurek MF, Chattha GK et al (1986) Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer\u2019s disease. Ann Neurol 20(3):282\u2013288","journal-title":"Ann Neurol"},{"key":"3328_CR29","doi-asserted-by":"crossref","unstructured":"Rai SN, Tiwari N, Singh P, et al (2022) Exploring the paradox of COVID-19 in neurological complications with emphasis on Parkinson\u2019s and Alzheimer\u2019s disease. Oxid Med Cell Longev\u00a0","DOI":"10.1155\/2022\/3012778"},{"key":"3328_CR30","doi-asserted-by":"crossref","unstructured":"Chen XY, Du YF, Chen L (2019) Neuropeptides exert neuroprotective effects in Alzheimer\u2019s disease. Front Mol Neurosci\u00a011","DOI":"10.3389\/fnmol.2018.00493"},{"issue":"2","key":"3328_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0304-3940(95)11973-Z","volume":"198","author":"S Koide","year":"1995","unstructured":"Koide S, Onishi H, Hashimoto H et al (1995) Plasma neuropeptide Y is reduced in patients with Alzheimer\u2019s disease. Neurosci Lett 198(2):149\u2013151","journal-title":"Neurosci Lett"},{"issue":"11","key":"3328_CR32","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/j.neurobiolaging.2005.09.022","volume":"27","author":"B Ramos","year":"2006","unstructured":"Ramos B, Baglietto-Vargas D, del Rio JC et al (2006) Early neuropathology of somatostatin\/NPY GABAergic cells in the hippocampus of a PS1xAPP transgenic model of Alzheimer\u2019s disease. Neurobiol Aging 27(11):1658\u20131672","journal-title":"Neurobiol Aging"},{"issue":"3","key":"3328_CR33","doi-asserted-by":"publisher","first-page":"154","DOI":"10.2174\/1871524919666190820160053","volume":"19","author":"AK Singh","year":"2019","unstructured":"Singh AK, Singh SK, Nandi MK et al (2019) Berberine: a plant-derived alkaloid with therapeutic potential to combat Alzheimer\u2019s disease. Cent Nerv Syst Agents Med Chem Bentham Science Publishers Ltd 19(3):154\u2013170","journal-title":"Cent Nerv Syst Agents Med Chem Bentham Science Publishers Ltd"},{"issue":"1","key":"3328_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/03639045.2019.1698594","volume":"46","author":"AK Singh","year":"2019","unstructured":"Singh AK, Mishra SK, Mishra G et al (2019) Inorganic clay nanocomposite system for improved cholinesterase inhibition and brain pharmacokinetics of donepezil. Taylor & Francis 46(1):8\u201319. https:\/\/doi.org\/10.1080\/03639045.2019.1698594","journal-title":"Taylor & Francis"},{"key":"3328_CR35","doi-asserted-by":"crossref","unstructured":"Houlton J, Abumaria N, Hinkley SFR, et al (2019) Therapeutic potential of neurotrophins for repair after brain injury: a helping hand from biomaterials. Front Neurosci\u00a0","DOI":"10.3389\/fnins.2019.00790"},{"issue":"1","key":"3328_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-0173(98)00004-6","volume":"27","author":"B Connor","year":"1998","unstructured":"Connor B, Dragunow M (1998) The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Rev 27(1):1\u201339","journal-title":"Brain Res Rev"},{"key":"3328_CR37","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1146\/annurev.neuro.24.1.1217","volume":"24","author":"MV Sofroniew","year":"2001","unstructured":"Sofroniew MV, Howe CL, Mobley WC (2001) Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 24:1217\u20131281","journal-title":"Annu Rev Neurosci"},{"issue":"11","key":"3328_CR38","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1586\/14737175.2014.969242","volume":"14","author":"A Berretta","year":"2014","unstructured":"Berretta A, Tzeng YC, Clarkson AN (2014) Post-stroke recovery: the role of activity-dependent release of brain-derived neurotrophic factor. Expert Rev Neurother 14(11):1335\u20131344","journal-title":"Expert Rev Neurother"},{"issue":"11","key":"3328_CR39","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1111\/j.1460-9568.2007.05591.x","volume":"25","author":"M Ploughman","year":"2007","unstructured":"Ploughman M, Attwood Z, White N et al (2007) Endurance exercise facilitates relearning of forelimb motor skill after focal ischemia. Eur J Neurosci 25(11):3453\u20133460","journal-title":"Eur J Neurosci"},{"issue":"4","key":"3328_CR40","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1161\/STROKEAHA.108.531806","volume":"40","author":"M Ploughman","year":"2009","unstructured":"Ploughman M, Windle V, MacLellan CL et al (2009) Brain-derived neurotrophic factor contributes to recovery of skilled reaching after focal ischemia in rats. Stroke 40(4):1490\u20131495","journal-title":"Stroke"},{"issue":"2","key":"3328_CR41","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.neuron.2010.03.035","volume":"66","author":"B Fritsch","year":"2010","unstructured":"Fritsch B, Reis J, Martinowich K et al (2010) Direct current stimulation promotes BDNF-dependent synaptic plasticity: potential implications for motor learning. Neuron 66(2):198\u2013204","journal-title":"Neuron"},{"issue":"10","key":"3328_CR42","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1523\/JNEUROSCI.5780-10.2011","volume":"31","author":"AN Clarkson","year":"2011","unstructured":"Clarkson AN, Overman JJ, Zhong S et al (2011) AMPA receptor-induced local brain-derived neurotrophic factor signaling mediates motor recovery after stroke. J Neurosci 31(10):3766\u20133775","journal-title":"J Neurosci"},{"issue":"4","key":"3328_CR43","doi-asserted-by":"publisher","first-page":"306","DOI":"10.17712\/nsj.2016.4.20160080","volume":"21","author":"MA Al-Qudah","year":"2016","unstructured":"Al-Qudah MA, Al-Dwairi A (2016) Mechanisms and regulation of neurotrophin synthesis and secretion. Neurosciences (Riyadh) 21(4):306\u201313","journal-title":"Neurosciences (Riyadh)"},{"issue":"Suppl 2","key":"3328_CR44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/head.13084","volume":"57","author":"AF Russo","year":"2017","unstructured":"Russo AF (2017) Overview of neuropeptides: awakening the senses? Headache Headache 57(Suppl 2):37\u201346","journal-title":"Headache Headache"},{"issue":"1","key":"3328_CR45","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1602\/neurorx.2.1.120","volume":"2","author":"D Wu","year":"2005","unstructured":"Wu D (2005) Neuroprotection in experimental stroke with targeted neurotrophins. NeuroRx 2(1):120\u2013128","journal-title":"NeuroRx"},{"issue":"5","key":"3328_CR46","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/00004647-199705000-00003","volume":"17","author":"WR Sch\u00e4bitz","year":"1997","unstructured":"Sch\u00e4bitz WR, Schwab S, Spranger M et al (1997) Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats. J Cereb Blood Flow Metab 17(5):500\u2013506","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"3328_CR47","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1023\/A:1022322025000","volume":"12","author":"K Yamashita","year":"1997","unstructured":"Yamashita K, Wiessner C, Lindholm D et al (1997) Post-occlusion treatment with BDNF reduces infarct size in a model of permanent occlusion of the middle cerebral artery in rat. Metab Brain Dis 12(4):271\u2013280","journal-title":"Metab Brain Dis"},{"issue":"2","key":"3328_CR48","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0006-8993(00)01966-1","volume":"859","author":"H Yanamoto","year":"2000","unstructured":"Yanamoto H, Nagata I, Sakata M et al (2000) Infarct tolerance induced by intra-cerebral infusion of recombinant brain-derived neurotrophic factor. Brain Res 859(2):240\u2013248","journal-title":"Brain Res"},{"issue":"9","key":"3328_CR49","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1161\/01.STR.31.9.2212","volume":"31","author":"WR Schabitz","year":"2000","unstructured":"Schabitz WR, Sommer C, Zoder W et al (2000) Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia. Stroke 31(9):2212\u20132217","journal-title":"Stroke"},{"issue":"9","key":"3328_CR50","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/sj.gt.3302224","volume":"11","author":"M Shirakura","year":"2004","unstructured":"Shirakura M, Inoue M, Fujikawa S et al (2004) Postischemic administration of Sendai virus vector carrying neurotrophic factor genes prevents delayed neuronal death in gerbils. Gene Ther 11(9):784\u2013790","journal-title":"Gene Ther"},{"issue":"5","key":"3328_CR51","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S0028-3908(00)00006-X","volume":"39","author":"J Chen","year":"2000","unstructured":"Chen J, Li Y, Chopp M (2000) Intracerebral transplantation of bone marrow with BDNF after MCAo in rat. Neuropharmacology 39(5):711\u2013716","journal-title":"Neuropharmacology"},{"issue":"2","key":"3328_CR52","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.expneurol.2003.10.008","volume":"185","author":"C Berger","year":"2004","unstructured":"Berger C, Schabitz WR, Wolf M et al (2004) Hypothermia and brain-derived neurotrophic factor reduce glutamate synergistically in acute stroke. Exp Neurol 185(2):305\u2013312","journal-title":"Exp Neurol"},{"issue":"9","key":"3328_CR53","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1161\/01.STR.0000138954.25825.0b","volume":"35","author":"CV Borlongan","year":"2004","unstructured":"Borlongan CV, Skinner SJM, Geaney M et al (2004) Intracerebral transplantation of porcine choroid plexus provides structural and functional neuroprotection in a rodent model of stroke. Stroke 35(9):2206\u20132210","journal-title":"Stroke"},{"issue":"1","key":"3328_CR54","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.expneurol.2008.01.027","volume":"211","author":"N Mochizuki","year":"2008","unstructured":"Mochizuki N, Takagi N, Kurokawa K et al (2008) Injection of neural progenitor cells improved learning and memory dysfunction after cerebral ischemia. Exp Neurol 211(1):194\u2013202","journal-title":"Exp Neurol"},{"issue":"2","key":"3328_CR55","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1161\/STROKEAHA.110.597344","volume":"42","author":"Y Hasegawa","year":"2011","unstructured":"Hasegawa Y, Suzuki H, Altay O et al (2011) Preservation of tropomyosin-related kinase B (TrkB) signaling by sodium orthovanadate attenuates early brain injury after subarachnoid hemorrhage in rats. Stroke 42(2):477\u2013483","journal-title":"Stroke"},{"issue":"2","key":"3328_CR56","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1177\/147323001103900216","volume":"39","author":"JM Zhu","year":"2011","unstructured":"Zhu JM, Zhao YY, Chen SD et al (2011) Functional recovery after transplantation of neural stem cells modified by brain-derived neurotrophic factor in rats with cerebral ischaemia. J Int Med Res 39(2):488\u2013498","journal-title":"J Int Med Res"},{"issue":"1","key":"3328_CR57","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neures.2009.05.010","volume":"65","author":"Y Sato","year":"2009","unstructured":"Sato Y, Chin Y, Kato T et al (2009) White matter activated glial cells produce BDNF in a stroke model of monkeys. Neurosci Res 65(1):71\u201378","journal-title":"Neurosci Res"},{"issue":"4","key":"3328_CR58","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1161\/01.STR.0000119754.85848.0D","volume":"35","author":"WR Sch\u00e4bitz","year":"2004","unstructured":"Sch\u00e4bitz WR, Berger C, Kollmar R et al (2004) Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia. Stroke 35(4):992\u2013997","journal-title":"Stroke"},{"issue":"12","key":"3328_CR59","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1046\/j.1460-9568.2003.02713.x","volume":"17","author":"E Gustafsson","year":"2003","unstructured":"Gustafsson E, Andsberg G, Darsalia V et al (2003) Anterograde delivery of brain-derived neurotrophic factor to striatum via nigral transduction of recombinant adeno-associated virus increases neuronal death but promotes neurogenic response following stroke. Eur J Neurosci 17(12):2667\u20132678","journal-title":"Eur J Neurosci"},{"issue":"1","key":"3328_CR60","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ymthe.2004.09.020","volume":"11","author":"K Kurozumi","year":"2005","unstructured":"Kurozumi K, Nakamura K, Tamiya T et al (2005) Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther Mol Ther 11(1):96\u2013104","journal-title":"Mol Ther Mol Ther"},{"issue":"1","key":"3328_CR61","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3390\/pharmaceutics5010127","volume":"5","author":"C G\u00e9ral","year":"2013","unstructured":"G\u00e9ral C, Angelova A, Lesieur S (2013) From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF). Pharmaceutics 5(1):127\u2013167","journal-title":"Pharmaceutics"},{"issue":"6","key":"3328_CR62","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1161\/01.STR.32.6.1378","volume":"32","author":"Y Zhang","year":"2001","unstructured":"Zhang Y, Pardridge WM (2001) Neuroprotection in transient focal brain ischemia after delayed intravenous administration of brain-derived neurotrophic factor conjugated to a blood-brain barrier drug targeting system. Stroke 32(6):1378\u20131383","journal-title":"Stroke"},{"issue":"1","key":"3328_CR63","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.brainres.2006.07.005","volume":"1111","author":"Y Zhang","year":"2006","unstructured":"Zhang Y, Pardridge WM (2006) Blood-brain barrier targeting of BDNF improves motor function in rats with middle cerebral artery occlusion. Brain Res 1111(1):227\u2013229","journal-title":"Brain Res"},{"key":"3328_CR64","doi-asserted-by":"crossref","unstructured":"Kumar Yadav M, Kumar Singh S, Singh M, et al (2019) Neurocognitive values of Evolvulus alsinoides and Centella asiatica on scopolamine induced amnesia in mice.\u00a0Am J Ethnomedicine\u00a06(1)","DOI":"10.36648\/2348-9502.6.1.15"},{"key":"3328_CR65","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.brainres.2008.03.011","volume":"1212","author":"H Yanamoto","year":"2008","unstructured":"Yanamoto H, Miyamoto S, Nakajo Y et al (2008) Repeated application of an electric field increases BDNF in the brain, enhances spatial learning, and induces infarct tolerance. Brain Res 1212:79\u201388","journal-title":"Brain Res"},{"issue":"22","key":"3328_CR66","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.1016\/j.biomaterials.2011.03.072","volume":"32","author":"Q Han","year":"2011","unstructured":"Han Q, Li B, Feng H et al (2011) The promotion of cerebral ischemia recovery in rats by laminin-binding BDNF. Biomaterials 32(22):5077\u20135085","journal-title":"Biomaterials"},{"key":"3328_CR67","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.neuroscience.2010.10.054","volume":"172","author":"Y Jiang","year":"2011","unstructured":"Jiang Y, Wei N, Lu T et al (2011) Intranasal brain-derived neurotrophic factor protects brain from ischemic insult via modulating local inflammation in rats. Neuroscience 172:398\u2013405","journal-title":"Neuroscience"},{"key":"3328_CR68","doi-asserted-by":"crossref","unstructured":"Fred JF\u00a0 (2008) Risk in CNS drug discovery: Focus on treatment of Alzheimer\u2019s disease. BMC Neurosci 9(3)","DOI":"10.1186\/1471-2202-9-S3-S1"},{"issue":"6","key":"3328_CR69","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1073\/pnas.0913572107","volume":"107","author":"SW Jang","year":"2010","unstructured":"Jang SW, Liu X, Yepes M et al (2010) A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. Proc Natl Acad Sci U S A 107(6):2687\u20132692","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3328_CR70","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.brainres.2006.09.063","volume":"1123","author":"ZZ Jun","year":"2006","unstructured":"Jun ZZ, Li P, Wang Z et al (2006) A comparative study on the individual and combined effects of baicalin and jasminoidin on focal cerebral ischemia-reperfusion injury. Brain Res 1123(1):188\u201395","journal-title":"Brain Res"},{"issue":"9","key":"3328_CR71","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1161\/STROKEAHA.110.589333","volume":"41","author":"X Cui","year":"2010","unstructured":"Cui X, Chopp M, Zacharek A et al (2010) Niacin treatment of stroke increases synaptic plasticity and axon growth in rats. Stroke 41(9):2044\u20132049","journal-title":"Stroke"},{"issue":"11","key":"3328_CR72","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1007\/s11064-010-0234-z","volume":"35","author":"WS Qu","year":"2010","unstructured":"Qu WS, Wang YH, Wang JP et al (2010) Galectin-1 enhances astrocytic BDNF production and improves functional outcome in rats following ischemia. Neurochem Res 35(11):1716\u20131724","journal-title":"Neurochem Res"},{"issue":"3","key":"3328_CR73","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10059-011-0028-4","volume":"31","author":"KY Kam","year":"2011","unstructured":"Kam KY, Yu SJ, Jeong N et al (2011) p-Hydroxybenzyl alcohol prevents brain injury and behavioral impairment by activating Nrf2, PDI, and neurotrophic factor genes in a rat model of brain ischemia. Mol Cells 31(3):209\u2013215","journal-title":"Mol Cells"},{"issue":"5","key":"3328_CR74","doi-asserted-by":"publisher","first-page":"698","DOI":"10.2174\/1871527311312050015","volume":"12","author":"R Rodrigo","year":"2013","unstructured":"Rodrigo R, Fernandez-Gajardo R, Gutierrez R et al (2013) Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities. CNS Neurol Disord Drug Targets 12(5):698\u2013714","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"3328_CR75","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.neuroscience.2012.10.014","volume":"239","author":"SM Rothman","year":"2013","unstructured":"Rothman SM, Mattson MP (2013) Activity-dependent, stress-responsive BDNF signaling and the quest for optimal brain health and resilience throughout the lifespan. Neuroscience 239:228\u2013240","journal-title":"Neuroscience"},{"issue":"3","key":"3328_CR76","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1460-9568.2011.07965.x","volume":"35","author":"A Markham","year":"2012","unstructured":"Markham A, Cameron I, Bains R et al (2012) Brain-derived neurotrophic factor-mediated effects on mitochondrial respiratory coupling and neuroprotection share the same molecular signalling pathways. Eur J Neurosci 35(3):366\u2013374","journal-title":"Eur J Neurosci"},{"issue":"7","key":"3328_CR77","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1161\/STROKEAHA.106.477331","volume":"38","author":"WR Sch\u00e4bitz","year":"2007","unstructured":"Sch\u00e4bitz WR, Steigleder T, Cooper-Kuhn CM et al (2007) Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke 38(7):2165\u20132172","journal-title":"Stroke"},{"issue":"1","key":"3328_CR78","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/NEN.0b013e31819308e9","volume":"68","author":"S Keiner","year":"2009","unstructured":"Keiner S, Witte OW, Redecker C (2009) Immunocytochemical detection of newly generated neurons in the perilesional area of cortical infarcts after intraventricular application of brain-derived neurotrophic factor. J Neuropathol Exp Neurol 68(1):83\u201393","journal-title":"J Neuropathol Exp Neurol"},{"issue":"8","key":"3328_CR79","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1021\/acsbiomaterials.1c00514","volume":"7","author":"AK Singh","year":"2021","unstructured":"Singh AK, Sen Singh S, Rathore AS et al (2021) Lipid-coated MCM-41 mesoporous silica nanoparticles loaded with berberine improved inhibition of acetylcholine esterase and amyloid formation. ACS Biomater Sci Eng 7(8):3737\u201353","journal-title":"ACS Biomater Sci Eng"},{"key":"3328_CR80","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.brainres.2010.02.030","volume":"1327","author":"B Li","year":"2010","unstructured":"Li B, Piao CS, Liu XY et al (2010) Brain self-protection: the role of endogenous neural progenitor cells in adult brain after cerebral cortical ischemia. Brain Res 1327:91\u2013102","journal-title":"Brain Res"},{"key":"3328_CR81","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.brainres.2010.10.063","volume":"1367","author":"X Bao","year":"2011","unstructured":"Bao X, Wei J, Feng M et al (2011) Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in rats. Brain Res 1367:103\u2013113","journal-title":"Brain Res"},{"issue":"4","key":"3328_CR82","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.neuroscience.2010.10.008","volume":"171","author":"Y Tanaka","year":"2010","unstructured":"Tanaka Y, Tanaka R, Liu M et al (2010) Cilostazol attenuates ischemic brain injury and enhances neurogenesis in the subventricular zone of adult mice after transient focal cerebral ischemia. Neuroscience 171(4):1367\u20131376","journal-title":"Neuroscience"},{"issue":"4","key":"3328_CR83","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1440-1789.2007.00792.x","volume":"27","author":"R Qu","year":"2007","unstructured":"Qu R, Li Y, Gao Q et al (2007) Neurotrophic and growth factor gene expression profiling of mouse bone marrow stromal cells induced by ischemic brain extracts. Neuropathology 27(4):355\u2013363","journal-title":"Neuropathology"},{"issue":"21","key":"3328_CR84","doi-asserted-by":"publisher","first-page":"7582","DOI":"10.1073\/pnas.0801105105","volume":"105","author":"S Guo","year":"2008","unstructured":"Guo S, Kim WJ, Lok J et al (2008) Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons. Proc Natl Acad Sci U S A 105(21):7582\u20137587","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"3328_CR85","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jns.2010.09.003","volume":"298","author":"YJ Choi","year":"2010","unstructured":"Choi YJ, Li WY, Moon GJ et al (2010) Enhancing trophic support of mesenchymal stem cells by ex vivo treatment with trophic factors. J Neurol Sci 298(1\u20132):28\u201334","journal-title":"J Neurol Sci"},{"key":"3328_CR86","doi-asserted-by":"crossref","unstructured":"Madinier A, Bertrand N, Mossiat C, et al (2009) Microglial involvement in neuroplastic changes following focal brain ischemia in rats. Plos One\u00a04(12)","DOI":"10.1371\/journal.pone.0008101"},{"key":"3328_CR87","doi-asserted-by":"crossref","unstructured":"Narantuya D, Nagai A, Abdullah M, et al (2010) Human microglia transplanted in rat focal ischemia brain induce neuroprotection and behavioral improvement. Plos One\u00a05(7)","DOI":"10.1371\/journal.pone.0011746"},{"issue":"9","key":"3328_CR88","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/nn1971","volume":"10","author":"K Martinowich","year":"2007","unstructured":"Martinowich K, Manji H, Lu B (2007) New insights into BDNF function in depression and anxiety. Nat Neurosci 10(9):1089\u20131093","journal-title":"Nat Neurosci"},{"issue":"5\u20136","key":"3328_CR89","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/FBP.0b013e3282ee2aa8","volume":"18","author":"HD Schmidt","year":"2007","unstructured":"Schmidt HD, Duman RS (2007) The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol 18(5\u20136):391\u2013418","journal-title":"Behav Pharmacol"},{"issue":"2","key":"3328_CR90","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0165-6147(99)01309-7","volume":"20","author":"CA Altar","year":"1999","unstructured":"Altar CA (1999) Neurotrophins and depression. Trends Pharmacol Sci 20(2):59\u201362","journal-title":"Trends Pharmacol Sci"},{"issue":"12","key":"3328_CR91","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.jpsychires.2006.09.009","volume":"41","author":"RM Post","year":"2007","unstructured":"Post RM (2007) Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. J Psychiatr Res 41(12):979\u2013990","journal-title":"J Psychiatr Res"},{"issue":"1","key":"3328_CR92","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.pharmthera.2007.07.001","volume":"117","author":"ME Kozisek","year":"2008","unstructured":"Kozisek ME, Middlemas D, Bylund DB (2008) Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies. Pharmacol Ther 117(1):30\u201351","journal-title":"Pharmacol Ther"},{"issue":"3","key":"3328_CR93","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.neulet.2005.12.085","volume":"398","author":"ABM Cunha","year":"2006","unstructured":"Cunha ABM, Frey BN, Andreazza AC et al (2006) Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett 398(3):215\u2013219","journal-title":"Neurosci Lett"},{"issue":"1\u20133","key":"3328_CR94","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.schres.2006.05.028","volume":"86","author":"A Palomino","year":"2006","unstructured":"Palomino A, Vallejo-Illarramendi A, Gonz\u00e1lez-Pinto A et al (2006) Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients. Schizophr Res 86(1\u20133):321\u2013322","journal-title":"Schizophr Res"},{"issue":"2","key":"3328_CR95","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0165-1781(02)00005-7","volume":"109","author":"F Karege","year":"2002","unstructured":"Karege F, Perret G, Bondolfi G et al (2002) Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109(2):143\u2013148","journal-title":"Psychiatry Res"},{"issue":"2","key":"3328_CR96","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neulet.2003.08.004","volume":"351","author":"E Shimizu","year":"2003","unstructured":"Shimizu E, Hashimoto K, Watanabe H et al (2003) Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls. Neurosci Lett 351(2):111\u2013114","journal-title":"Neurosci Lett"},{"issue":"2","key":"3328_CR97","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.pnpbp.2004.11.009","volume":"29","author":"O Aydemir","year":"2005","unstructured":"Aydemir O, Deveci A, Taneli F (2005) The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 29(2):261\u2013265","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"3328_CR98","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1159\/000085725","volume":"51","author":"N Gervasoni","year":"2005","unstructured":"Gervasoni N, Aubry JM, Bondolfi G et al (2005) Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 51(4):234\u2013238","journal-title":"Neuropsychobiology"},{"issue":"6","key":"3328_CR99","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00406-005-0578-6","volume":"255","author":"AS Gonul","year":"2005","unstructured":"Gonul AS, Akdeniz F, Taneli F et al (2005) Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci 255(6):381\u2013386","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"4","key":"3328_CR100","doi-asserted-by":"publisher","first-page":"512","DOI":"10.4088\/JCP.v68n0404","volume":"68","author":"CM Marano","year":"2007","unstructured":"Marano CM, Phatak P, Vemulapalli UR et al (2007) Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression. J Clin Psychiatry 68(4):512\u2013517","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"3328_CR101","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.euroneuro.2006.04.010","volume":"16","author":"L Bocchio-Chiavetto","year":"2006","unstructured":"Bocchio-Chiavetto L, Zanardini R, Bortolomasi M et al (2006) Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients. Eur Neuropsychopharmacol 16(8):620\u2013624","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1\u20132","key":"3328_CR102","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.molbrainres.2004.12.020","volume":"136","author":"F Karege","year":"2005","unstructured":"Karege F, Vaudan G, Schwald M et al (2005) Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol 136(1\u20132):29\u201337","journal-title":"Brain Res Mol"},{"issue":"3","key":"3328_CR103","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.biopsych.2004.10.019","volume":"57","author":"EF Torrey","year":"2005","unstructured":"Torrey EF, Barci BM, Webster MJ et al (2005) Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol Psychiatry 57(3):252\u2013260","journal-title":"Biol Psychiatry"},{"issue":"8","key":"3328_CR104","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1001\/archpsyc.60.8.804","volume":"60","author":"Y Dwivedi","year":"2003","unstructured":"Dwivedi Y, Rizavi HS, Conley RR et al (2003) Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 60(8):804\u2013815","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"3328_CR105","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0006-3223(01)01083-6","volume":"50","author":"B Chen","year":"2001","unstructured":"Chen B, Dowlatshahi D, MacQueen GM et al (2001) Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50(4):260\u2013265","journal-title":"Biol Psychiatry"},{"issue":"2","key":"3328_CR106","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.bbr.2008.10.006","volume":"197","author":"S Thakker-Varia","year":"2009","unstructured":"Thakker-Varia S, Alder J (2009) Neuropeptides in depression: role of VGF. Behav Brain Res 197(2):262\u2013278","journal-title":"Behav Brain Res"},{"issue":"4","key":"3328_CR107","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.pbb.2006.11.021","volume":"85","author":"J Gr\u00f8nli","year":"2006","unstructured":"Gr\u00f8nli J, Bramham C, Murison R et al (2006) Chronic mild stress inhibits BDNF protein expression and CREB activation in the dentate gyrus but not in the hippocampus proper. Pharmacol Biochem Behav 85(4):842\u2013849","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"3328_CR108","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neures.2005.06.008","volume":"53","author":"S Murakami","year":"2005","unstructured":"Murakami S, Imbe H, Morikawa Y et al (2005) Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly. Neurosci Res 53(2):129\u2013139","journal-title":"Neurosci Res"},{"issue":"3 Pt 1","key":"3328_CR109","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1523\/JNEUROSCI.15-03-01768.1995","volume":"15","author":"MA Smith","year":"1995","unstructured":"Smith MA, Makino S, Kvetnansky R et al (1995) Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 15(3 Pt 1):1768\u20131777","journal-title":"J Neurosci"},{"issue":"1","key":"3328_CR110","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/00124509-200103000-00006","volume":"17","author":"ACH Chen","year":"2001","unstructured":"Chen ACH, Shin KH, Duman RS et al (2001) ECS-Induced mossy fiber sprouting and BDNF expression are attenuated by ketamine pretreatment. J ECT J ECT 17(1):27\u201332","journal-title":"J ECT J ECT"},{"issue":"7","key":"3328_CR111","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0006-3223(03)00073-8","volume":"54","author":"CA Altar","year":"2003","unstructured":"Altar CA, Whitehead RE, Chen R et al (2003) Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol Psychiatry 54(7):703\u2013709","journal-title":"Biol Psychiatry"},{"issue":"11","key":"3328_CR112","doi-asserted-by":"publisher","first-page":"7539","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995","volume":"15","author":"M Nibuya","year":"1995","unstructured":"Nibuya M, Morinobu S, Duman RS (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15(11):7539\u20137547","journal-title":"J Neurosci"},{"issue":"12","key":"3328_CR113","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1038\/sj.npp.1300514","volume":"29","author":"AA Russo-Neustadt","year":"2004","unstructured":"Russo-Neustadt AA, Alejandre H, Garcia C et al (2004) Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise. Neuropsychopharmacology 29(12):2189\u20132199","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"3328_CR114","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0169-328X(98)00077-1","volume":"57","author":"TSC Zetterstr\u00f6m","year":"1998","unstructured":"Zetterstr\u00f6m TSC, Pei Q, Grahame-Smith DG (1998) Repeated electroconvulsive shock extends the duration of enhanced gene expression for BDNF in rat brain compared with a single administration. Mol Brain Res 57(1):106\u2013110","journal-title":"Mol Brain Res"},{"issue":"1","key":"3328_CR115","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/sj.npp.1301571","volume":"33","author":"K Martinowich","year":"2008","unstructured":"Martinowich K, Lu B (2008) Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 33(1):73\u201383","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"3328_CR116","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0028-3908(03)00077-7","volume":"44","author":"AL Coppell","year":"2003","unstructured":"Coppell AL, Pei Q, Zetterstr\u00f6m TSC (2003) Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology 44(7):903\u2013910","journal-title":"Neuropharmacology"},{"issue":"8","key":"3328_CR117","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1523\/JNEUROSCI.17-08-02785.1997","volume":"17","author":"VA Vaidya","year":"1997","unstructured":"Vaidya VA, Marek GJ, Aghajanian GK et al (1997) 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J Neurosci 17(8):2785\u20132795","journal-title":"J Neurosci"},{"issue":"7","key":"3328_CR118","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/S0028-3908(99)00022-2","volume":"38","author":"TSC Zetterstr\u00f6m","year":"1999","unstructured":"Zetterstr\u00f6m TSC, Pei Q, Madhav TR et al (1999) Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain. Neuropharmacology 38(7):1063\u20131073","journal-title":"Neuropharmacology"},{"issue":"3","key":"3328_CR119","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.neuroscience.2007.04.045","volume":"147","author":"G de Foubert","year":"2007","unstructured":"de Foubert G, O\u2019Neill MJ, Zetterstr\u00f6m TSC (2007) Acute onset by 5-HT(6)-receptor activation on rat brain brain-derived neurotrophic factor and activity-regulated cytoskeletal-associated protein mRNA expression. Neuroscience 147(3):778\u2013785","journal-title":"Neuroscience"},{"key":"3328_CR120","doi-asserted-by":"crossref","unstructured":"Siuciak JA, Clark MS, Rind HB, et al (1998) BDNF induction of tryptophan hydroxylase mRNA levels in the rat brain. J Neurosci Res.\u00a0Wiley Online Library [cited 2023]. Available at: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/(SICI)1097-4547(19980415)52:2%3C149::AIDJNR3%3E3.0.CO;2-A","DOI":"10.1002\/(SICI)1097-4547(19980415)52:2<149::AID-JNR3>3.0.CO;2-A"},{"issue":"7","key":"3328_CR121","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1046\/j.1460-9568.1999.00667.x","volume":"11","author":"D Galter","year":"1999","unstructured":"Galter D, Bottner M, Krieglstein K et al (1999) Differential regulation of distinct phenotypic features of serotonergic neurons by bone morphogenetic proteins. Eur J Neurosci 11(7):2444\u20132452","journal-title":"Eur J Neurosci"},{"issue":"6","key":"3328_CR122","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1046\/j.1471-4159.2002.01264.x","volume":"83","author":"P Rumajogee","year":"2002","unstructured":"Rumajogee P, Madeira A, Verg\u00e9 D et al (2002) Up-regulation of the neuronal serotoninergic phenotype in vitro: BDNF and cAMP share Trk B-dependent mechanisms. J Neurochem 83(6):1525\u20131528","journal-title":"J Neurochem"},{"issue":"4","key":"3328_CR123","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/jnr.20572","volume":"81","author":"P Rumajogee","year":"2005","unstructured":"Rumajogee P, Verg\u00e9 D, Darmon M et al (2005) Rapid up-regulation of the neuronal serotoninergic phenotype by brain-derived neurotrophic factor and cyclic adenosine monophosphate: relations with raphe astrocytes. J Neurosci Res 81(4):481\u2013487","journal-title":"J Neurosci Res"},{"issue":"1\u20132","key":"3328_CR124","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jneumeth.2004.03.026","volume":"140","author":"ME Szapacs","year":"2004","unstructured":"Szapacs ME, Mathews TA, Tessarollo L et al (2004) Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression. J Neurosci Methods 140(1\u20132):81\u201392","journal-title":"J Neurosci Methods"},{"issue":"3","key":"3328_CR125","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1471-4159.2006.04392.x","volume":"101","author":"LC Daws","year":"2007","unstructured":"Daws LC, Munn JL, Valdez MF et al (2007) Serotonin transporter function, but not expression, is dependent on brain-derived neurotrophic factor (BDNF): in vivo studies in BDNF-deficient mice. J Neurochem 101(3):641\u2013651","journal-title":"J Neurochem"},{"issue":"9","key":"3328_CR126","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tins.2007.06.011","volume":"30","author":"CW Cotman","year":"2007","unstructured":"Cotman CW, Berchtold NC, Christie LA (2007) Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci 30(9):464\u2013472","journal-title":"Trends Neurosci"},{"issue":"6","key":"3328_CR127","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0166-2236(02)02143-4","volume":"25","author":"CW Cotman","year":"2002","unstructured":"Cotman CW, Berchtold NC (2002) Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci 25(6):295\u2013301","journal-title":"Trends Neurosci"},{"issue":"5","key":"3328_CR128","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0893-133X(99)00059-7","volume":"21","author":"A Russo-Neustadt","year":"1999","unstructured":"Russo-Neustadt A, Beard RC, Cotman CW (1999) Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology 21(5):679\u2013682","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"3328_CR129","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.neuroscience.2005.03.026","volume":"133","author":"NC Berchtold","year":"2005","unstructured":"Berchtold NC, Chinn G, Chou M et al (2005) Exercise primes a molecular memory for brain-derived neurotrophic factor protein induction in the rat hippocampus. Neuroscience 133(3):853\u2013861","journal-title":"Neuroscience"},{"issue":"5\u20136","key":"3328_CR130","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1440-1681.2007.04610.x","volume":"34","author":"HE Grote","year":"2007","unstructured":"Grote HE, Hannan AJ (2007) Regulators of adult neurogenesis in the healthy and diseased brain. Clin Exp Pharmacol Physiol 34(5\u20136):533\u2013545","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"5852","key":"3328_CR131","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1126\/science.1147851","volume":"318","author":"LN Manganas","year":"2007","unstructured":"Manganas LN, Zhang X, Li Y et al (2007) Magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain. Science 318(5852):980\u2013985","journal-title":"Science"},{"issue":"3","key":"3328_CR132","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1073\/pnas.0337481100","volume":"100","author":"GM MacQueen","year":"2003","unstructured":"MacQueen GM, Campbell S, McEwen BS et al (2003) Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci U S A 100(3):1387\u20131392","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3328_CR133","doi-asserted-by":"publisher","first-page":"5","DOI":"10.64719\/pb.4260","volume":"35","author":"HK Manji","year":"2001","unstructured":"Manji HK, Duman RS (2001) Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol Bull 35(2):5\u201349","journal-title":"Psychopharmacol Bull"},{"issue":"9","key":"3328_CR134","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1073\/pnas.93.9.3908","volume":"93","author":"YI Sheline","year":"1996","unstructured":"Sheline YI, Wang PW, Gado MH et al (1996) Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A 93(9):3908\u20133913","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"3328_CR135","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1523\/JNEUROSCI.12-09-03642.1992","volume":"12","author":"E Gould","year":"1992","unstructured":"Gould E, Cameron HA, Daniels DC et al (1992) Adrenal hormones suppress cell division in the adult rat dentate gyrus. J Neurosci 12(9):3642\u20133650","journal-title":"J Neurosci"},{"issue":"3\u20134","key":"3328_CR136","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0736-5748(98)00029-X","volume":"16","author":"P Tanapat","year":"1998","unstructured":"Tanapat P, Galea LAM, Gould E (1998) Stress inhibits the proliferation of granule cell precursors in the developing dentate gyrus. Int J Dev Neurosci 16(3\u20134):235\u201339","journal-title":"Int J Dev Neurosci"},{"issue":"22","key":"3328_CR137","doi-asserted-by":"publisher","first-page":"12796","DOI":"10.1073\/pnas.211427898","volume":"98","author":"B Cz\u00e9h","year":"2001","unstructured":"Cz\u00e9h B, Michaelis T, Watanabe T et al (2001) Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci U S A 98(22):12796\u201312801","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"3328_CR138","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1038\/sj.npp.1300234","volume":"28","author":"JE Malberg","year":"2003","unstructured":"Malberg JE, Duman RS (2003) Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology 28(9):1562\u20131571","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"3328_CR139","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1046\/j.1460-9568.2003.02513.x","volume":"17","author":"K Pham","year":"2003","unstructured":"Pham K, Nacher J, Hof PR et al (2003) Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus. Eur J Neurosci 17(4):879\u2013886","journal-title":"Eur J Neurosci"},{"issue":"5839","key":"3328_CR140","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1144400","volume":"317","author":"RD Airan","year":"2007","unstructured":"Airan RD, Meltzer LA, Roy M et al (2007) High-speed imaging reveals neurophysiological links to behavior in an animal model of depression. Science 317(5839):819\u2013823","journal-title":"Science"},{"issue":"5634","key":"3328_CR141","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.1083328","volume":"301","author":"L Santarelli","year":"2003","unstructured":"Santarelli L, Saxe M, Gross C et al (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301(5634):805\u2013809","journal-title":"Science"},{"issue":"10","key":"3328_CR142","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/S0006-3223(03)00527-4","volume":"54","author":"B Vollmayr","year":"2003","unstructured":"Vollmayr B, Simonis C, Weber S et al (2003) Reduced cell proliferation in the dentate gyrus is not correlated with the development of learned helplessness. Biol Psychiatry 54(10):1035\u20131040","journal-title":"Biol Psychiatry"},{"issue":"9","key":"3328_CR143","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/nn1969","volume":"10","author":"A Sahay","year":"2007","unstructured":"Sahay A, Hen R (2007) Adult hippocampal neurogenesis in depression. Nat Neurosci 10(9):1110\u20131115","journal-title":"Nat Neurosci"},{"issue":"24","key":"3328_CR144","doi-asserted-by":"publisher","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","volume":"20","author":"JE Malberg","year":"2000","unstructured":"Malberg JE, Eisch AJ, Nestler EJ et al (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20(24):9104\u20139110","journal-title":"J Neurosci"},{"issue":"1","key":"3328_CR145","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.bbr.2005.04.013","volume":"163","author":"K N\u00e1m\u011bstkov\u00e1","year":"2005","unstructured":"N\u00e1m\u011bstkov\u00e1 K, \u0160imonov\u00e1 Z, Sykov\u00e1 E (2005) Decreased proliferation in the adult rat hippocampus after exposure to the Morris water maze and its reversal by fluoxetine. Behav Brain Res 163(1):26\u201332","journal-title":"Behav Brain Res"},{"issue":"9","key":"3328_CR146","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1523\/JNEUROSCI.22-09-03673.2002","volume":"22","author":"S Nakagawa","year":"2002","unstructured":"Nakagawa S, Kim JE, Lee R et al (2002) Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. J Neurosci 22(9):3673\u20133682","journal-title":"J Neurosci"},{"issue":"2","key":"3328_CR147","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.expneurol.2004.11.016","volume":"192","author":"H Scharfman","year":"2005","unstructured":"Scharfman H, Goodman J, Macleod A et al (2005) Increased neurogenesis and the ectopic granule cells after intrahippocampal BDNF infusion in adult rats. Exp Neurol 192(2):348\u2013356","journal-title":"Exp Neurol"},{"issue":"18","key":"3328_CR148","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1523\/JNEUROSCI.0237-07.2007","volume":"27","author":"TD Perera","year":"2007","unstructured":"Perera TD, Coplan JD, Lisanby SH et al (2007) Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates. J Neurosci 27(18):4894\u20134901","journal-title":"J Neurosci"},{"issue":"8","key":"3328_CR149","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1176\/appi.ajp.160.8.1516","volume":"160","author":"YI Sheline","year":"2003","unstructured":"Sheline YI, Gado MH, Kraemer HC (2003) Untreated depression and hippocampal volume loss. Am J Psychiatry 160(8):1516\u20131518","journal-title":"Am J Psychiatry"},{"issue":"7","key":"3328_CR150","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0006-3223(03)00634-6","volume":"54","author":"E Vermetten","year":"2003","unstructured":"Vermetten E, Vythilingam M, Southwick SM et al (2003) Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder. Biol Psychiatry 54(7):693\u2013702","journal-title":"Biol Psychiatry"},{"issue":"12","key":"3328_CR151","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1097\/00001756-199808240-00030","volume":"9","author":"T Nishio","year":"1998","unstructured":"Nishio T, Furukawa S, Akiguchi I et al (1998) Medial nigral dopamine neurons have rich neurotrophin support in humans. Neuroreport 9(12):2847\u20132851","journal-title":"Neuroreport"},{"issue":"7","key":"3328_CR152","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1097\/00001756-199805110-00073","volume":"9","author":"T Nishio","year":"1998","unstructured":"Nishio T, Sunohara N, Furukawa S (1998) Neutrophin switching in spinal motoneurons of amyotrophic lateral sclerosis. Neuroreport 9(7):1661\u20131665","journal-title":"Neuroreport"},{"issue":"2","key":"3328_CR153","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1006\/mcne.2001.1016","volume":"18","author":"M Fahnestock","year":"2001","unstructured":"Fahnestock M, Michalski B, Xu B et al (2001) The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer\u2019s disease. Mol Cell Neurosci 18(2):210\u2013220","journal-title":"Mol Cell Neurosci"},{"issue":"2","key":"3328_CR154","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0169-328X(00)00023-1","volume":"76","author":"RMD Holsinger","year":"2000","unstructured":"Holsinger RMD, Schnarr J, Henry P et al (2000) Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer\u2019s disease. Mol Brain Res 76(2):347\u2013354","journal-title":"Mol Brain Res"},{"issue":"7","key":"3328_CR155","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/00005072-199907000-00007","volume":"58","author":"I Ferrer","year":"1999","unstructured":"Ferrer I, Mar\u00edn C, Rey MJ et al (1999) BDNF and full-length and truncated TrkB expression in Alzheimer disease Implications in therapeutic strategies. J Neuropathol Exp Neurol 58(7):729\u201339","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"3328_CR156","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1006\/bbrc.1999.1561","volume":"264","author":"SJ Allen","year":"1999","unstructured":"Allen SJ, Wilcock GK, Dawbarn D (1999) Profound and selective loss of catalytic TrkB immunoreactivity in Alzheimer\u2019s disease. Biochem Biophys Res Commun 264(3):648\u2013651","journal-title":"Biochem Biophys Res Commun"},{"issue":"2\u20133","key":"3328_CR157","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0165-0173(00)00030-8","volume":"33","author":"GJ Siegel","year":"2000","unstructured":"Siegel GJ, Chauhan NB (2000) Neurotrophic factors in Alzheimer\u2019s and Parkinson\u2019s disease brain. Brain Res Brain Res Rev 33(2\u20133):199\u2013227","journal-title":"Brain Res Brain Res Rev"},{"issue":"1","key":"3328_CR158","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0022-510X(96)00312-7","volume":"148","author":"RM Duberley","year":"1997","unstructured":"Duberley RM, Johnson IP, Anand P et al (1997) Neurotrophin-3-like immunoreactivity and Trk C expression in human spinal motoneurones in amyotrophic lateral sclerosis. J Neurol Sci 148(1):33\u201340","journal-title":"J Neurol Sci"},{"issue":"2","key":"3328_CR159","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1023\/A:1007575504321","volume":"25","author":"T Mutoh","year":"2000","unstructured":"Mutoh T, Sobue G, Hamano T et al (2000) Decreased phosphorylation levels of TrkB neurotrophin receptor in the spinal cords from patients with amyotrophic lateral sclerosis. Neurochem Res 25(2):239\u2013245","journal-title":"Neurochem Res"},{"issue":"2","key":"3328_CR160","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1006\/exnr.2002.8011","volume":"177","author":"BM K\u00fcst","year":"2002","unstructured":"K\u00fcst BM, Copray JCVM, Brouwer N et al (2002) Elevated levels of neurotrophins in human biceps brachii tissue of amyotrophic lateral sclerosis. Exp Neurol 177(2):419\u2013427","journal-title":"Exp Neurol"},{"issue":"6","key":"3328_CR161","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1006\/mcne.1996.0031","volume":"7","author":"WD Snider","year":"1996","unstructured":"Snider WD, Lichtman JW (1996) Are neurotrophins synaptotrophins? Mol Cell Neurosci 7(6):433\u2013442","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"3328_CR162","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1083\/jcb.119.1.123","volume":"119","author":"RG Parton","year":"1992","unstructured":"Parton RG, Simons K, Dotti CG (1992) Axonal and dendritic endocytic pathways in cultured neurons. J Cell Biol 119(1):123\u2013137","journal-title":"J Cell Biol"},{"key":"3328_CR163","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev.ne.14.030191.002321","volume":"14","author":"RW Oppenheim","year":"1991","unstructured":"Oppenheim RW (1991) Cell death during development of the nervous system. Annu Rev Neurosci 14:453\u2013501","journal-title":"Annu Rev Neurosci"},{"key":"3328_CR164","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1101\/SQB.1996.061.01.042","volume":"61","author":"EC Beattie","year":"1996","unstructured":"Beattie EC, Zhou J, Grimes ML et al (1996) A signaling endosome hypothesis to explain ngf actions: potential implications for neurodegeneration. Cold Spring Harb Symp Quant Biol 61:389\u2013406","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"2","key":"3328_CR165","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S1097-2765(02)00607-X","volume":"10","author":"J Schlessinger","year":"2002","unstructured":"Schlessinger J (2002) All signaling is local? Mol Cell 10(2):218\u2013219","journal-title":"Mol Cell"},{"issue":"5559","key":"3328_CR166","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1126\/science.1064913","volume":"295","author":"BL MacInnis","year":"2002","unstructured":"MacInnis BL, Campenot RB (2002) Retrograde support of neuronal survival without retrograde transport of nerve growth factor. Science 295(5559):1536\u20131539","journal-title":"Science"},{"issue":"8","key":"3328_CR167","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/PL00000917","volume":"58","author":"KE Neet","year":"2001","unstructured":"Neet KE, Campenot RB (2001) Receptor binding, internalization, and retrograde transport of neurotrophic factors. Cell Mol Life Sci 58(8):1021\u20131035","journal-title":"Cell Mol Life Sci"},{"issue":"5496","key":"3328_CR168","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1126\/science.290.5496.1567","volume":"290","author":"PJ Verveer","year":"2000","unstructured":"Verveer PJ, Wouters FS, Reynolds AR et al (2000) Quantitative imaging of lateral ErbB1 receptor signal propagation in the plasma membrane. Science 290(5496):1567\u20131570","journal-title":"Science"},{"issue":"6","key":"3328_CR169","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/ana.410100602","volume":"10","author":"SH Appel","year":"1981","unstructured":"Appel SH (1981) A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease. Ann Neurol 10(6):499\u2013505","journal-title":"Ann Neurol"},{"issue":"2","key":"3328_CR170","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000112334","volume":"6","author":"S Varon","year":"1983","unstructured":"Varon S, Manthorpe M, Williams LR (1983) Neuronotrophic and neurite-promoting factors and their clinical potentials. Dev Neurosci 6(2):73\u2013100","journal-title":"Dev Neurosci"},{"issue":"8","key":"3328_CR171","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.1073\/pnas.081070898","volume":"98","author":"M Zhang","year":"2001","unstructured":"Zhang M, Dwyer NK, Love DC et al (2001) Cessation of rapid late endosomal tubulovesicular trafficking in Niemann-Pick type C1 disease. Natl Acad Sci U S A 98(8):4466\u20134471","journal-title":"Natl Acad Sci U S A"},{"issue":"26","key":"3328_CR172","doi-asserted-by":"publisher","first-page":"20179","DOI":"10.1074\/jbc.M001793200","volume":"275","author":"LP Henderson","year":"2000","unstructured":"Henderson LP, Lin L, Prasad A et al (2000) Embryonic striatal neurons from Niemann-Pick type C mice exhibit defects in cholesterol metabolism and neurotrophin responsiveness. J Biol Chem 275(26):20179\u201320187","journal-title":"J Biol Chem"},{"issue":"5","key":"3328_CR173","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.physbeh.2009.02.043","volume":"97","author":"S Herness","year":"2009","unstructured":"Herness S, li Zhao F (2009) The neuropeptides CCK and NPY and the changing view of cell-to-cell communication in the taste bud. Physiol Behav 97(5):581\u201391","journal-title":"Physiol Behav"},{"issue":"3\u20134","key":"3328_CR174","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0167-0115(86)90048-0","volume":"13","author":"C Wahlestedt","year":"1986","unstructured":"Wahlestedt C, Yanaihara N, H\u00e5kanson R (1986) Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides. Regul Pept 13(3\u20134):307\u2013318","journal-title":"Regul Pept"},{"issue":"2\u20133","key":"3328_CR175","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0014-2999(97)01258-2","volume":"336","author":"BJ McDermott","year":"1997","unstructured":"McDermott BJ, Millar BC, Dolan FM et al (1997) Evidence for Y1 and Y2 subtypes of neuropeptide Y receptors linked to opposing postjunctional effects observed in rat cardiac myocytes. Eur J Pharmacol 336(2\u20133):257\u2013265","journal-title":"Eur J Pharmacol"},{"issue":"32","key":"3328_CR176","doi-asserted-by":"publisher","first-page":"7406","DOI":"10.1523\/JNEUROSCI.1008-05.2005","volume":"25","author":"C Acuna-Goycolea","year":"2005","unstructured":"Acuna-Goycolea C, Tamamaki N, Yanagawa Y et al (2005) Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus. J Neurosci 25(32):7406\u20137419","journal-title":"J Neurosci"},{"key":"3328_CR177","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3389\/fnins.2019.00869","volume":"13","author":"C Li","year":"2019","unstructured":"Li C, Wu X, Liu S et al (2019) Roles of neuropeptide Y in neurodegenerative and neuroimmune diseases. Front Neurosci 13:869","journal-title":"Front Neurosci"},{"issue":"3","key":"3328_CR178","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3233\/JAD-2011-110713","volume":"28","author":"ME Soto","year":"2012","unstructured":"Soto ME, Secher M, Gillette-Guyonnet S et al (2012) Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer\u2019s disease. J Alzheimers Dis 28(3):647\u2013654","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"3328_CR179","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4142\/jvs.2018.19.3.319","volume":"19","author":"Y Seo","year":"2018","unstructured":"Seo Y, Kim HS, Kang KS (2018) Microglial involvement in the development of olfactory dysfunction. J Vet Sci 19(3):319\u2013330","journal-title":"J Vet Sci"},{"issue":"6","key":"3328_CR180","first-page":"1411","volume":"160","author":"L Zhang","year":"2019","unstructured":"Zhang L, Hernandez-Sanchez D, Herzog H (2019) Regulation of feeding-related behaviors by arcuate neuropeptide Y neurons. Endocrinology 160(6):1411\u20131420","journal-title":"Endocrinology"},{"key":"3328_CR181","doi-asserted-by":"crossref","unstructured":"Albanese E, Launer LJ, Egger M, et al\u00a0 (2017) Body mass index in midlife and dementia: Systematic review and meta-regression analysis of 589,649 men and women followed in longitudinal studies. Alzheimers Dement (Amst) 8:165\u201378","DOI":"10.1016\/j.dadm.2017.05.007"},{"issue":"5580","key":"3328_CR182","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297(5580):353\u2013356","journal-title":"Science"},{"issue":"1","key":"3328_CR183","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.neuron.2006.09.016","volume":"52","author":"J Hardy","year":"2006","unstructured":"Hardy J (2006) A hundred years of Alzheimer\u2019s disease research. Neuron 52(1):3\u201313","journal-title":"Neuron"},{"issue":"1","key":"3328_CR184","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12017-009-8104-z","volume":"12","author":"VW Chow","year":"2010","unstructured":"Chow VW, Mattson MP, Wong PC et al (2010) An overview of APP processing enzymes and products. Neuromolecular Med 12(1):1\u201312","journal-title":"Neuromolecular Med"},{"key":"3328_CR185","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/(SICI)1097-4547(20000515)60:4<565::AID-JNR16>3.0.CO;2-I","volume":"60","author":"J-P Lee","year":"2000","unstructured":"Lee J-P, Chang K-A, Kim H-S et al (2000) APP carboxyl-terminal fragment without or with a domain equally induces cytotoxicity in differentiated PC12 cells and cortical neurons. J Neurosci Res 60:565\u2013570","journal-title":"J Neurosci Res"},{"issue":"8","key":"3328_CR186","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1073\/pnas.89.8.3448","volume":"89","author":"RL Neve","year":"1992","unstructured":"Neve RL, Kammesheidt A, Hommann CF (1992) Brain transplants of cells expressing the carboxyl-terminal fragment of the Alzheimer amyloid protein precursor cause specific neuropathology in vivo. Proc Natl Acad Sci U S A 89(8):3448\u20133452","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"3328_CR187","doi-asserted-by":"publisher","first-page":"10857","DOI":"10.1073\/pnas.89.22.10857","volume":"89","author":"A Kammesheidt","year":"1992","unstructured":"Kammesheidt A, Boyce FM, Spanoyannis AF et al (1992) Deposition of beta\/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain. Proc Natl Acad Sci U S A 89(22):10857\u201310861","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"3328_CR188","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","volume":"8","author":"DW Dickson","year":"2009","unstructured":"Dickson DW, Braak H, Duda JE et al (2009) Neuropathological assessment of Parkinson\u2019s disease: refining the diagnostic criteria. Lancet Neurol 8(12):1150\u20131157","journal-title":"Lancet Neurol"},{"key":"3328_CR189","doi-asserted-by":"crossref","unstructured":"Snyder CH, Adler CH (2007) The patient with Parkinson\u2019s disease: Part I - Treating the motor symptoms; Part II - Treating the nonmotor symptoms. J Am Acad Nurse Pract 19(4):179\u201397","DOI":"10.1111\/j.1745-7599.2007.00211.x"},{"issue":"1","key":"3328_CR190","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrneurol.2011.189","volume":"8","author":"D Aarsland","year":"2011","unstructured":"Aarsland D, P\u00e5hlhagen S, Ballard CG et al (2011) Depression in Parkinson disease\u2013epidemiology, mechanisms and management. Nat Rev Neurol 8(1):35\u201347","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"3328_CR191","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1002\/mds.22212","volume":"23","author":"I Boileau","year":"2008","unstructured":"Boileau I, Warsh JJ, Guttman M et al (2008) Elevated serotonin transporter binding in depressed patients with Parkinson\u2019s disease: a preliminary PET study with [11C]DASB. Mov Disord 23(12):1776\u20131780","journal-title":"Mov Disord"},{"key":"3328_CR192","first-page":"870","volume":"44","author":"SE Kim","year":"2003","unstructured":"Kim SE, Joon J, Choi Y et al (2003) Serotonin transporters in the midbrain of Parkinson\u2019s disease patients: a study with 123 I-CIT SPECT. J Nucl Med 44:870\u201376","journal-title":"J Nucl Med"},{"issue":"6","key":"3328_CR193","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1176\/ajp.143.6.756","volume":"143","author":"R Mayeux","year":"1986","unstructured":"Mayeux R, Stern Y, Williams JBW et al (1986) Clinical and biochemical features of depression in Parkinson\u2019s disease. Am J Psychiatry 143(6):756\u2013759","journal-title":"Am J Psychiatry"},{"key":"3328_CR194","doi-asserted-by":"crossref","unstructured":"Gusella JF, MacDonald ME (2009) Huntington\u2019s disease: The case for genetic modifiers. Genome Med Genome Med 1(8)","DOI":"10.1186\/gm80"},{"issue":"15","key":"3328_CR195","doi-asserted-by":"publisher","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","volume":"85","author":"A Reiner","year":"1988","unstructured":"Reiner A, Albin RL, Anderson KD et al (1988) Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A 85(15):5733\u20135737","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"3328_CR196","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1755-5949.2010.00134.x","volume":"16","author":"VM Andr\u00e9","year":"2010","unstructured":"Andr\u00e9 VM, Cepeda C, Levine MS (2010) Dopamine and glutamate in Huntington\u2019s disease: a balancing act. CNS Neurosci Ther 16(3):163\u2013178","journal-title":"CNS Neurosci Ther"},{"issue":"6","key":"3328_CR197","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.npep.2012.09.001","volume":"46","author":"JO Malva","year":"2012","unstructured":"Malva JO, Xapelli S, Baptista S et al (2012) Multifaces of neuropeptide Y in the brain\u2013neuroprotection, neurogenesis and neuroinflammation. Neuropeptides 46(6):299\u2013308","journal-title":"Neuropeptides"},{"issue":"2","key":"3328_CR198","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00109-013-1092-3","volume":"92","author":"E Kloster","year":"2014","unstructured":"Kloster E, Saft C, Akkad DA et al (2014) Association of age at onset in Huntington disease with functional promoter variations in NPY and NPY2R. J Mol Med (Berl) 92(2):177\u201384","journal-title":"J Mol Med (Berl)"},{"issue":"2","key":"3328_CR199","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00705-005-0626-6","volume":"151","author":"S Cook","year":"2006","unstructured":"Cook S, Holmes EC (2006) A multigene analysis of the phylogenetic relationships among the flaviviruses (Family: Flaviviridae) and the evolution of vector transmission. Arch Virol 151(2):309\u2013325","journal-title":"Arch Virol"},{"issue":"5","key":"3328_CR200","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/0035-9203(52)90043-6","volume":"46","author":"GWA Dick","year":"1952","unstructured":"Dick GWA (1952) Zika virus II Pathogenicity and physical properties. Trans R Soc Trop Med Hyg 46(5):521\u201334","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"3328_CR201","first-page":"679","volume":"28","author":"C Brito","year":"2015","unstructured":"Brito C (2015) Zika virus: a new chapter in the history of medicine. Acta Med 28(6):679\u2013680","journal-title":"Acta Med"},{"issue":"9497","key":"3328_CR202","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","volume":"366","author":"RAC Hughes","year":"2005","unstructured":"Hughes RAC, Cornblath DR (2005) Guillain-Barr\u00e9 syndrome. Lancet 366(9497):1653\u20131666","journal-title":"Lancet"},{"issue":"4","key":"3328_CR203","doi-asserted-by":"publisher","first-page":"7","DOI":"10.15407\/biotech9.04.007","volume":"9","author":"F Can","year":"2016","unstructured":"Can F (2016) The current approaches to zika virus vaccination. Biotechnol Acta 9(4):7\u201313","journal-title":"Biotechnol Acta"},{"issue":"5","key":"3328_CR204","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000017069","volume":"9","author":"ME J\u00f6nhagen","year":"1998","unstructured":"J\u00f6nhagen ME, Nordberg A, Amberla K et al (1998) Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 9(5):246\u2013257","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"5","key":"3328_CR205","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/0197-4580(89)90117-6","volume":"10","author":"RT Bartus","year":"1989","unstructured":"Bartus RT (1989) Neurotrophic factors: can the degenerating brain be induced to heal itself? Neurobiol Aging 10(5):513","journal-title":"Neurobiol Aging"},{"key":"3328_CR206","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0074-7742(02)50083-0","volume":"50","author":"SC Apfel","year":"2002","unstructured":"Apfel SC (2002) Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold? Int Rev Neurobiol 50:393\u2013413","journal-title":"Int Rev Neurobiol"},{"issue":"5","key":"3328_CR207","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nm850","volume":"9","author":"SS Gill","year":"2003","unstructured":"Gill SS, Patel NK, Hotton GR et al (2003) Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 9(5):589\u2013595","journal-title":"Nat Med"},{"issue":"5","key":"3328_CR208","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nm1239","volume":"11","author":"MH Tuszynski","year":"2005","unstructured":"Tuszynski MH, Thal L, Pay M et al (2005) A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 11(5):551\u2013555","journal-title":"Nat Med"},{"issue":"5","key":"3328_CR209","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S1474-4422(08)70065-6","volume":"7","author":"WJ Marks","year":"2008","unstructured":"Marks WJ, Ostrem JL, Verhagen L et al (2008) Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson\u2019s disease: an open-label, phase I trial. Lancet Neurol 7(5):400\u2013408","journal-title":"Lancet Neurol"},{"issue":"1","key":"3328_CR210","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ana.22453","volume":"70","author":"RL Alterman","year":"2011","unstructured":"Alterman RL, Tagliati M, Olanow CW (2011) Open-label surgical trials for Parkinson disease: time for reconsideration. Ann Neurol 70(1):5\u20138","journal-title":"Ann Neurol"},{"issue":"12","key":"3328_CR211","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/S1474-4422(10)70254-4","volume":"9","author":"WJ Marks","year":"2010","unstructured":"Marks WJ, Bartus RT, Siffert J et al (2010) Gene delivery of AAV2-neurturin for Parkinson\u2019s disease: a double-blind, randomised, controlled trial. Lancet Neurol 9(12):1164\u20131172","journal-title":"Lancet Neurol"},{"issue":"3","key":"3328_CR212","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/cne.903630302","volume":"363","author":"DM Gash","year":"1995","unstructured":"Gash DM, Zhang Z, Cass WA et al (1995) Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys. J Comp Neurol 363(3):345\u2013358","journal-title":"J Comp Neurol"},{"issue":"2","key":"3328_CR213","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1006\/exnr.1998.6887","volume":"154","author":"DL Choi-Lundberg","year":"1998","unstructured":"Choi-Lundberg DL, Lin Q, Schallert T et al (1998) Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor. Exp Neurol 154(2):261\u2013275","journal-title":"Exp Neurol"},{"issue":"3602","key":"3328_CR214","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1126\/science.143.3602.105","volume":"143","author":"R Levi-Montalcini","year":"1964","unstructured":"Levi-Montalcini R (1964) Growth control of nerve cells by a protein factor and its antiserum: discovery of this factor may provide new leads to understanding of some neurogenetic processes. Science 143(3602):105\u2013110","journal-title":"Science"},{"issue":"3","key":"3328_CR215","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1073\/pnas.46.3.384","volume":"46","author":"R Levi-Montalcini","year":"1960","unstructured":"Levi-Montalcini R, Booker B (1960) Destruction of the sympathetic ganglia in mammals by an antiserum to a nerve-growth protein. Proc Natl Acad Sci U S A 46(3):384\u2013391","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"3328_CR216","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1523\/JNEUROSCI.06-10-03031.1986","volume":"6","author":"JE Johnson","year":"1986","unstructured":"Johnson JE, Barde YA, Schwab M et al (1986) Brain-derived neurotrophic factor supports the survival of cultured rat retinal ganglion cells. J Neurosci 6(10):3031\u20133038","journal-title":"J Neurosci"},{"issue":"4","key":"3328_CR217","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/0896-6273(90)90089-X","volume":"5","author":"PC Maisonpierre","year":"1990","unstructured":"Maisonpierre PC, Belluscio L, Friedman B et al (1990) NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression. Neuron 5(4):501\u2013509","journal-title":"Neuron"},{"issue":"5","key":"3328_CR218","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1523\/JNEUROSCI.5100-09.2010","volume":"30","author":"S Rauskolb","year":"2010","unstructured":"Rauskolb S, Zagrebelsky M, Dreznjak A et al (2010) Global deprivation of brain-derived neurotrophic factor in the CNS reveals an area-specific requirement for dendritic growth. J Neurosci 30(5):1739\u20131749","journal-title":"J Neurosci"},{"issue":"17","key":"3328_CR219","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1523\/JNEUROSCI.3920-03.2004","volume":"24","author":"ZC Baquet","year":"2004","unstructured":"Baquet ZC, Gorski JA, Jones KR (2004) Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J Neurosci 24(17):4250\u20134258","journal-title":"J Neurosci"},{"issue":"26","key":"3328_CR220","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.1523\/JNEUROSCI.4601-04.2005","volume":"25","author":"ZC Baquet","year":"2005","unstructured":"Baquet ZC, Bickford PC, Jones KR (2005) Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta. J Neurosci 25(26):6251\u20136259","journal-title":"J Neurosci"},{"issue":"27","key":"3328_CR221","doi-asserted-by":"publisher","first-page":"7234","DOI":"10.1523\/JNEUROSCI.1943-07.2007","volume":"27","author":"K Kohara","year":"2007","unstructured":"Kohara K, Yasuda H, Huang Y et al (2007) A local reduction in cortical GABAergic synapses after a loss of endogenous brain-derived neurotrophic factor, as revealed by single-cell gene knock-out method. J Neurosci 27(27):7234\u20137244","journal-title":"J Neurosci"},{"issue":"6553","key":"3328_CR222","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/378192a0","volume":"378","author":"S Cohen-Cory","year":"1995","unstructured":"Cohen-Cory S, Fraser SE (1995) Effects of brain-derived neurotrophic factor on optic axon branching and remodelling in vivo. Nature 378(6553):192\u2013196","journal-title":"Nature"},{"issue":"17","key":"3328_CR223","doi-asserted-by":"publisher","first-page":"6856","DOI":"10.1523\/JNEUROSCI.23-17-06856.2003","volume":"23","author":"JA Gorski","year":"2003","unstructured":"Gorski JA, Zeiler SR, Tamowski S et al (2003) Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. J Neurosci 23(17):6856\u20136865","journal-title":"J Neurosci"},{"issue":"5\u20136","key":"3328_CR224","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1006\/mcne.1997.0641","volume":"9","author":"A Cellerino","year":"1997","unstructured":"Cellerino A, Carroll P, Thoenen H et al (1997) Reduced size of retinal ganglion cell axons and hypomyelination in mice lacking brain-derived neurotrophic factor. Mol Cell Neurosci 9(5\u20136):397\u2013408","journal-title":"Mol Cell Neurosci"},{"key":"3328_CR225","doi-asserted-by":"crossref","unstructured":"Mukherjee D, Patil CG (2011) Epidemiology and the global burden of stroke. World Neurosurg 76(6 Suppl)","DOI":"10.1016\/j.wneu.2011.07.023"},{"key":"3328_CR226","doi-asserted-by":"crossref","unstructured":"McDermott M, Skolarus LE, Burke JF (2019) A systematic review and meta-analysis of interventions to increase stroke thrombolysis. BMC Neurol\u00a019(1)","DOI":"10.1186\/s12883-019-1298-2"},{"key":"3328_CR227","doi-asserted-by":"crossref","unstructured":"Feuerstein GZ, Chavez J (2009) Translational medicine for stroke drug discovery: the pharmaceutical industry perspective. Stroke\u00a040(3 Suppl. 1)","DOI":"10.1161\/STROKEAHA.108.535104"},{"issue":"3","key":"3328_CR228","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/1941875211408731","volume":"1","author":"DJ Miller","year":"2011","unstructured":"Miller DJ, Simpson JR, Silver B et al (2011) Safety of thrombolysis in acute ischemic stroke: a review of complications, risk factors, and newer technologies. Neurohospitalist 1(3):138\u2013147","journal-title":"Neurohospitalist"},{"issue":"3","key":"3328_CR229","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1124\/pr.109.002451","volume":"62","author":"SF Traynelis","year":"2010","unstructured":"Traynelis SF, Wollmuth LP, McBain CJ et al (2010) Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62(3):405\u2013496","journal-title":"Pharmacol Rev"},{"issue":"5","key":"3328_CR230","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1747-4949.2012.00770.x","volume":"7","author":"BA Sutherland","year":"2012","unstructured":"Sutherland BA, Minnerup J, Balami JS et al (2012) Neuroprotection for ischaemic stroke: translation from the bench to the bedside. Int J Stroke 7(5):407\u2013418","journal-title":"Int J Stroke"},{"issue":"3","key":"3328_CR231","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0959-4388(00)00092-1","volume":"10","author":"DR Kaplan","year":"2000","unstructured":"Kaplan DR, Miller FD (2000) Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 10(3):381\u2013391","journal-title":"Curr Opin Neurobiol"},{"issue":"5","key":"3328_CR232","first-page":"549","volume":"1","author":"YA Barde","year":"1982","unstructured":"Barde YA, Edgar D, Thoenen H (1982) Purification of a new neurotrophic factor from mammalian brain. EMBO J John Wiley & Sons, Ltd 1(5):549\u2013553","journal-title":"EMBO J John Wiley & Sons, Ltd"},{"issue":"1","key":"3328_CR233","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuron.2012.06.012","volume":"75","author":"TC S\u00fcdhof","year":"2012","unstructured":"S\u00fcdhof TC (2012) The presynaptic active zone. Neuron 75(1):11\u201325","journal-title":"Neuron"},{"issue":"7050","key":"3328_CR234","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/nature03809","volume":"436","author":"D Sieburth","year":"2005","unstructured":"Sieburth D, Ch\u2019ng Q, Dybbs M et al (2005) Systematic analysis of genes required for synapse structure and function. Nature 436(7050):510\u201317","journal-title":"Nature"},{"issue":"5","key":"3328_CR235","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1159\/000124582","volume":"43","author":"H Gainer","year":"1986","unstructured":"Gainer H, Wolfe SA, Obaid AL et al (1986) Action potentials and frequency-dependent secretion in the mouse neurohypophysis. Neuroendocrinol Karger Publishers 43(5):557\u2013563","journal-title":"Neuroendocrinol Karger Publishers"},{"issue":"3","key":"3328_CR236","first-page":"805","volume":"215","author":"JJ Dreifuss","year":"1971","unstructured":"Dreifuss JJ, Kalnins I, Kelly JS et al (1971) Action potentials and release of neurohypophysial hormones in vitro. J Physiol John Wiley & Sons, Ltd 215(3):805\u2013817","journal-title":"J Physiol John Wiley & Sons, Ltd"},{"issue":"1","key":"3328_CR237","first-page":"45","volume":"369","author":"M Cazalis","year":"1985","unstructured":"Cazalis M, Dayanithi G, Nordmann JJ (1985) The role of patterned burst and interburst interval on the excitation-coupling mechanism in the isolated rat neural lobe. J Physiol John Wiley & Sons, Ltd 369(1):45\u201360","journal-title":"J Physiol John Wiley & Sons, Ltd"},{"issue":"5","key":"3328_CR238","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1159\/000123248","volume":"33","author":"RJ Bicknell","year":"1981","unstructured":"Bicknell RJ, Leng G (1981) Relative efficiency of neural firing patterns for vasopressin release in vitro. Neuroendocrinol Karger Publishers 33(5):295\u2013299","journal-title":"Neuroendocrinol Karger Publishers"},{"issue":"2","key":"3328_CR239","first-page":"433","volume":"290","author":"A Dutton","year":"1979","unstructured":"Dutton A, Dyball REJ (1979) Phasic firing enhances vasopressin release from the rat neurohypophysis. J Physiol John Wiley & Sons, Ltd 290(2):433\u2013440","journal-title":"J Physiol John Wiley & Sons, Ltd"},{"issue":"18","key":"3328_CR240","doi-asserted-by":"publisher","first-page":"6773","DOI":"10.1523\/JNEUROSCI.20-18-06773.2000","volume":"20","author":"M Muschol","year":"2000","unstructured":"Muschol M, Salzberg BM (2000) Dependence of transient and residual calcium dynamics on action-potential patterning during neuropeptide secretion. J Neurosci 20(18):6773\u20136780","journal-title":"J Neurosci"},{"issue":"2","key":"3328_CR241","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1073\/pnas.88.2.380","volume":"88","author":"MB Jackson","year":"1991","unstructured":"Jackson MB, Konnerth A, Augustine GJ (1991) Action potential broadening and frequency-dependent facilitation of calcium signals in pituitary nerve terminals. Proc Natl Acad Sci U S A 88(2):380\u2013384","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"3328_CR242","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1159\/000124829","volume":"46","author":"CA Bondy","year":"1987","unstructured":"Bondy CA, Gainer H, Russell JT (1987) Effects of stimulus frequency and potassium channel blockade on the secretion of vasopressin and oxytocin from the neurohypophysis. Neuroendocrinol Karger Publishers 46(3):258\u2013267","journal-title":"Neuroendocrinol Karger Publishers"},{"issue":"1","key":"3328_CR243","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1749-6632.1975.tb34185.x","volume":"248","author":"JJ Dreifuss","year":"1975","unstructured":"Dreifuss JJ (1975) A review on neurosecretory granules: their contents and mechanisms of release. Ann N Y Acad Sci John Wiley & Sons, Ltd 248(1):184\u2013201","journal-title":"Ann N Y Acad Sci John Wiley & Sons, Ltd"},{"issue":"1 I","key":"3328_CR244","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1073\/pnas.81.1.180","volume":"81","author":"JJ Nordmann","year":"1984","unstructured":"Nordmann JJ, Morris JF (1984) Method for quantitating the molecular content of a subcellular organelle Hormone and neurophysin content of newly formed and aged neurosecretory granules. Proc Natl Acad Sci U S A 81(1 I):180\u201384","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"3328_CR245","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1523\/JNEUROSCI.12-09-03545.1992","volume":"12","author":"MD Whim","year":"1992","unstructured":"Whim MD, Lloyd PE (1992) Modulation of peptide release from single identified Aplysia neurons in culture. J Neurosci Soc Neurosci 12(9):3545\u20133553","journal-title":"J Neurosci Soc Neurosci"},{"issue":"7","key":"3328_CR246","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1523\/JNEUROSCI.13-07-02790.1993","volume":"13","author":"PJ Church","year":"1993","unstructured":"Church PJ, Whim MD, Lloyd PE (1993) Modulation of neuromuscular transmission by conventional and peptide transmitters released from excitatory and inhibitory motor neurons in Aplysia. J Neurosci Soc Neurosci 13(7):2790\u20132800","journal-title":"J Neurosci Soc Neurosci"},{"issue":"1","key":"3328_CR247","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1091\/mbc.e07-03-0261","volume":"19","author":"RV Barkus","year":"2008","unstructured":"Barkus RV, Klyachko O, Horiuchi D et al (2008) Identification of an axonal kinesin-3 motor for fast anterograde vesicle transport that facilitates retrograde transport of neuropeptides. Mol Biol Cell Am Soc Cell Biol 19(1):274\u2013283","journal-title":"Mol Biol Cell Am Soc Cell Biol"},{"issue":"5","key":"3328_CR248","first-page":"1029","volume":"148","author":"MY Wong","year":"2012","unstructured":"Wong MY, Zhou C, Shakiryanova D et al (2012) Neuropeptide delivery to synapses by long-range vesicle circulation and sporadic capture. Cell Elsevier B.V. 148(5):1029\u201338","journal-title":"Cell Elsevier B.V."},{"issue":"1","key":"3328_CR249","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-11-1","volume":"11","author":"JA Sobota","year":"2010","unstructured":"Sobota JA, Mohler WA, Cowan AE et al (2010) Dynamics of peptidergic secretory granule transport are regulated by neuronal stimulation. BMC Neurosci BioMed Central 11(1):1\u201315","journal-title":"BMC Neurosci BioMed Central"},{"issue":"6893","key":"3328_CR250","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nature00852","volume":"418","author":"VA Klyachko","year":"2002","unstructured":"Klyachko VA, Jackson MB (2002) Capacitance steps and fusion pores of small and large-dense-core vesicles in nerve terminals. Nature 418(6893):89\u201392","journal-title":"Nature"},{"issue":"7","key":"3328_CR251","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1523\/JNEUROSCI.23-07-02726.2003","volume":"23","author":"KCPJ De","year":"2003","unstructured":"De KCPJ, Wierda KDB, Bosman LWJ et al (2003) Somatodendritic secretion in oxytocin neurons is upregulated during the female reproductive cycle. J Neurosci Soc Neurosci 23(7):2726\u20132734","journal-title":"J Neurosci Soc Neurosci"},{"issue":"6","key":"3328_CR252","first-page":"857","volume":"18","author":"T Lang","year":"1997","unstructured":"Lang T, Wacker I, Steyer J et al (1997) Ca1+-triggered peptide secretion in single cells imaged with green fluorescent protein and evanescent-wave microscopy. Neuron Cell Press 18(6):857\u2013863","journal-title":"Neuron Cell Press"},{"issue":"5","key":"3328_CR253","first-page":"1095","volume":"19","author":"NV Burke","year":"1997","unstructured":"Burke NV, Han W, Li D et al (1997) Neuronal peptide release is limited by secretory granule mobility. Neuron Cell Press 19(5):1095\u20131102","journal-title":"Neuron Cell Press"},{"issue":"5","key":"3328_CR254","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/0896-6273(95)90336-4","volume":"14","author":"TA Ryan","year":"1995","unstructured":"Ryan TA, Smith SJ (1995) Vesicle pool mobilization during action potential firing at hippocampal synapses. Neuron 14(5):983\u2013989","journal-title":"Neuron"},{"issue":"5","key":"3328_CR255","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.neuron.2010.08.003","volume":"67","author":"SH Kim","year":"2010","unstructured":"Kim SH, Ryan TA (2010) CDK5 serves as a major control point in neurotransmitter release. Neuron 67(5):797\u2013809","journal-title":"Neuron"},{"key":"3328_CR256","doi-asserted-by":"crossref","unstructured":"Ariel M (2010) What\u2019s under the big-tent pragmatics? Defining Pragmatics. Cambridge University Press, pp 1\u2013330","DOI":"10.1017\/CBO9780511777912.003"},{"issue":"6","key":"3328_CR257","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nn.3099","volume":"15","author":"PY Pan","year":"2012","unstructured":"Pan PY, Ryan TA (2012) Calbindin controls release probability in ventral tegmental area dopamine neurons. Nat Neurosci 15(6):813\u2013815","journal-title":"Nat Neurosci"},{"issue":"11","key":"3328_CR258","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.1210\/en.2011-1416","volume":"152","author":"LC Fuenzalida","year":"2011","unstructured":"Fuenzalida LC, Keen KL, Terasawa E (2011) Colocalization of FM1-43, Bassoon, and GnRH-1: GnRH-1 release from cell bodies and their neuroprocesses. Endocrinol Oxford Acad 152(11):4310\u20134321","journal-title":"Endocrinol Oxford Acad"},{"issue":"6558","key":"3328_CR259","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/378730a0","volume":"378","author":"E Lingueglia","year":"1995","unstructured":"Lingueglia E, Champigny G, Lazdunski M et al (1995) Cloning of the amiloride-sensitive FMRFamide peptide-gated sodium channel. Nature 378(6558):730\u2013733","journal-title":"Nature"},{"issue":"1","key":"3328_CR260","first-page":"37","volume":"30","author":"MD Whim","year":"2001","unstructured":"Whim MD, Moss GWJ (2001) A novel technique that measures peptide secretion on a millisecond timescale reveals rapid changes in release. Neuron Cell Press 30(1):37\u201350","journal-title":"Neuron Cell Press"},{"issue":"4","key":"3328_CR261","doi-asserted-by":"publisher","first-page":"e19478","DOI":"10.1371\/journal.pone.0019478","volume":"6","author":"MD Whim","year":"2011","unstructured":"Whim MD (2011) Pancreatic beta cells synthesize neuropeptide Y and can rapidly release peptide co-transmitters. Plos One Public Lib Sci 6(4):e19478","journal-title":"Plos One Public Lib Sci"},{"issue":"24","key":"3328_CR262","doi-asserted-by":"publisher","first-page":"6637","DOI":"10.1523\/JNEUROSCI.5100-05.2006","volume":"26","author":"MD Whim","year":"2006","unstructured":"Whim MD (2006) Near simultaneous release of classical and peptide cotransmitters from chromaffin cells. J Neurosci 26(24):6637\u20136642","journal-title":"J Neurosci"},{"issue":"3","key":"3328_CR263","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nn.2505","volume":"13","author":"Y Ji","year":"2010","unstructured":"Ji Y, Lu Y, Yang F et al (2010) Acute and gradual increases in BDNF concentration elicit distinct signaling and functions in neurons. Nature Neurosci 13(3):302\u201309","journal-title":"Nature Neurosci"},{"issue":"3\u20135","key":"3328_CR264","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.pneurobio.2006.02.007","volume":"78","author":"WD Willis","year":"2006","unstructured":"Willis WD (2006) John Eccles\u2019 studies of spinal cord presynaptic inhibition. Prog Neurobiol 78(3\u20135):189\u2013214","journal-title":"Prog Neurobiol"},{"key":"3328_CR265","doi-asserted-by":"crossref","unstructured":"Miller RJ (1998)  Presynaptic receptors. Annu Rev Pharmacol Toxicol 38:201\u201327","DOI":"10.1146\/annurev.pharmtox.38.1.201"},{"issue":"10","key":"3328_CR266","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1523\/JNEUROSCI.08-10-03827.1988","volume":"8","author":"WF Colmers","year":"1988","unstructured":"Colmers WF, Lukowiak K, Pittman QJ (1988) Neuropeptide Y action in the rat hippocampal slice: site and mechanism of presynaptic inhibition. J Neurosci Soc Neurosci 8(10):3827\u20133837","journal-title":"J Neurosci Soc Neurosci"},{"issue":"4","key":"3328_CR267","first-page":"1032","volume":"108","author":"VG L\u00f3pez-Huerta","year":"2012","unstructured":"L\u00f3pez-Huerta VG, Blanco-Hern\u00e1ndez E, Bargas J et al (2012) Presynaptic modulation by somatostatin in the rat neostriatum is altered in a model of parkinsonism. J Neurophysiol Am Physiol Soc Bethesda, MD 108(4):1032\u20131043","journal-title":"J Neurophysiol Am Physiol Soc Bethesda, MD"},{"issue":"6","key":"3328_CR268","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1152\/jn.1997.78.6.3008","volume":"78","author":"MK Tallent","year":"1997","unstructured":"Tallent MK, Siggins GR (1997) Somatostatin depresses excitatory but not inhibitory neurotransmission in rat CA1 hippocampus. J Neurophysiol Am Physiol Soc 78(6):3008\u20133018","journal-title":"J Neurophysiol Am Physiol Soc"},{"issue":"19","key":"3328_CR269","doi-asserted-by":"publisher","first-page":"7962","DOI":"10.1523\/JNEUROSCI.18-19-07962.1998","volume":"18","author":"PAN Van Den","year":"1998","unstructured":"Van Den PAN, Gao XB, Obrietan K et al (1998) Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin\/orexin. J Neurosci Soc Neurosci 18(19):7962\u20137971","journal-title":"J Neurosci Soc Neurosci"},{"key":"3328_CR270","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0079-6123(07)63017-9","volume":"163","author":"G Sperk","year":"2007","unstructured":"Sperk G, Hamilton T, Colmers WF (2007) Neuropeptide Y in the dentate gyrus. Prog Brain Res 163:285\u2013297","journal-title":"Prog Brain Res"},{"issue":"23","key":"3328_CR271","doi-asserted-by":"publisher","first-page":"8927","DOI":"10.1523\/JNEUROSCI.17-23-08927.1997","volume":"17","author":"SC Baraban","year":"1997","unstructured":"Baraban SC, Hollopeter G, Erickson JC et al (1997) Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J Neuroscience Soc Neurosci 17(23):8927\u20138936","journal-title":"J Neuroscience Soc Neurosci"},{"issue":"23","key":"3328_CR272","doi-asserted-by":"publisher","first-page":"13518","DOI":"10.1073\/pnas.96.23.13518","volume":"96","author":"DJ Marsh","year":"1999","unstructured":"Marsh DJ, Baraban SC, Hollopeter G et al (1999) Role of the Y5 neuropeptide Y receptor in limbic seizures. Proc Natl Acad Sci U S A 96(23):13518\u201313523","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"50","key":"3328_CR273","doi-asserted-by":"publisher","first-page":"16970","DOI":"10.1523\/JNEUROSCI.2306-10.2010","volume":"30","author":"CJ Giesbrecht","year":"2010","unstructured":"Giesbrecht CJ, Mackay JP, Silveira HB et al (2010) Countervailing modulation of Ihby neuropeptide Y and corticotrophin-releasing factor in basolateral amygdala as a possible mechanism for their effects on stress-related behaviors. J Neurosci 30(50):16970\u201316982","journal-title":"J Neurosci"},{"issue":"2","key":"3328_CR274","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nrn1845","volume":"7","author":"M Ludwig","year":"2006","unstructured":"Ludwig M, Leng G (2006) Dendritic peptide release and peptide-dependent behaviours. Nat Rev 7(2):126\u201336","journal-title":"Nat Rev"},{"issue":"11","key":"3328_CR275","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1073\/pnas.1017837108","volume":"108","author":"D Shakiryanova","year":"2011","unstructured":"Shakiryanova D, Zettel GM, Gu T et al (2011) Synaptic neuropeptide release induced by octopamine without Ca2+ entry into the nerve terminal. Proc Natl Acad Sci U S A 108(11):4477\u20134481","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3328_CR276","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1469-7793.2001.0237b.x","volume":"533","author":"XB Gao","year":"2001","unstructured":"Gao XB, Van Den PAN (2001) Melanin concentrating hormone depresses synaptic activity of glutamate and GABA neurons from rat lateral hypothalamus. J Physiol 533(1):237\u2013252","journal-title":"J Physiol"},{"issue":"4","key":"3328_CR277","first-page":"955","volume":"132","author":"HS Gompf","year":"2005","unstructured":"Gompf HS, Moldavan MG, Irwin RP et al (2005) Nociceptin\/orphanin FQ (N\/OFQ) inhibits excitatory and inhibitory synaptic signaling in the suprachiasmatic nucleus (SCN). Neurosci Elsevier Ltd 132(4):955\u2013965","journal-title":"Neurosci Elsevier Ltd"},{"issue":"25","key":"3328_CR278","doi-asserted-by":"publisher","first-page":"9715","DOI":"10.1073\/pnas.0601899103","volume":"103","author":"M Roberto","year":"2006","unstructured":"Roberto M, Siggins GR (2006) Nociceptin\/orphanin FQ presynaptically decreases GABAergic transmission and blocks the ethanol-induced increase of GABA release in central amygdala. Proc Natl Acad Sci U S A 103(25):9715\u20139720","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6419","key":"3328_CR279","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/362423a0","volume":"362","author":"MG Weisskopf","year":"1993","unstructured":"Weisskopf MG, Zalutsky RA, Nicoll RA (1993) The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation. Nature 362(6419):423\u2013427","journal-title":"Nature"},{"issue":"19","key":"3328_CR280","doi-asserted-by":"publisher","first-page":"5942","DOI":"10.1523\/JNEUROSCI.16-19-05942.1996","volume":"16","author":"PE Castillo","year":"1996","unstructured":"Castillo PE, Salin PA, Weisskopf MG et al (1996) Characterizing the site and mode of action of dynorphin at hippocampal mossy fiber synapses in the guinea pig. J Neurosci Soc Neurosci 16(19):5942\u20135950","journal-title":"J Neurosci Soc Neurosci"},{"issue":"12","key":"3328_CR281","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1523\/JNEUROSCI.6032-11.2012","volume":"32","author":"MS Dicken","year":"2012","unstructured":"Dicken MS, Tooker RE, Hentges ST (2012) Regulation of gaba and glutamate release from proopiomelanocortin neuron terminals in intact hypothalamic networks. J Neurosci 32(12):4042\u20134048","journal-title":"J Neurosci"},{"issue":"40","key":"3328_CR282","doi-asserted-by":"publisher","first-page":"8741","DOI":"10.1523\/JNEUROSCI.2268-04.2004","volume":"24","author":"LY Fu","year":"2004","unstructured":"Fu LY, Acuna-Goycolea C, Van Den PAN (2004) Neuropeptide Y inhibits hypocretin\/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system. J Neurosci 24(40):8741\u20138751","journal-title":"J Neurosci"},{"issue":"8","key":"3328_CR283","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1111\/j.1460-9568.2008.06397.x","volume":"28","author":"SL Borgland","year":"2008","unstructured":"Borgland SL, Storm E, Bonci A (2008) Orexin B\/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons. Eur J Neurosci 28(8):1545\u20131556","journal-title":"Eur J Neurosci"},{"issue":"3","key":"3328_CR284","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1523\/JNEUROSCI.19-03-01072.1999","volume":"19","author":"TL Horvath","year":"1999","unstructured":"Horvath TL, Diano S, Van Den PAN (1999) Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations. J Neurosci Soc Neurosci 19(3):1072\u20131087","journal-title":"J Neurosci Soc Neurosci"},{"issue":"6836","key":"3328_CR285","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/35078085","volume":"411","author":"MA Cowley","year":"2001","unstructured":"Cowley MA, Smart JL, Rubinstein M et al (2001) Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411(6836):480\u2013484","journal-title":"Nature"},{"issue":"5","key":"3328_CR286","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrn2834","volume":"11","author":"C L\u00fcscher","year":"2010","unstructured":"L\u00fcscher C, Slesinger PA (2010) Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease. Nat Rev Neurosci 11(5):301\u201315","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"3328_CR287","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrn2668","volume":"10","author":"R Luj\u00e1n","year":"2009","unstructured":"Luj\u00e1n R, Maylie J, Adelman JP (2009) New sites of action for GIRK and SK channels. Nat Rev Neurosci 10(7):475\u201380","journal-title":"Nat Rev Neurosci"}],"updated-by":[{"DOI":"10.1007\/s12035-025-05509-w","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000}}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03328-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-023-03328-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03328-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T04:30:16Z","timestamp":1762317016000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-023-03328-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":287,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["3328"],"URL":"https:\/\/doi.org\/10.1007\/s12035-023-03328-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,13]]},"assertion":[{"value":"28 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12035-025-05509-w","URL":"https:\/\/doi.org\/10.1007\/s12035-025-05509-w","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}